EN DE

CorVel Corp (CRVL) Fair Value & Analysis

Financial Services · US · Market cap $3.2B · ISIN US2210061097

What is CorVel Corp really worth?

CC CorVel Corp logo CorVel Corp CRVL · US
Price$68.68
Fair Value$39.55
Upside−42.4%
Quality68/100

A solid business, but trading 74% above our fair value of $39.55.

Watch CorVel Corp for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free

Strengths

Solidly profitable · 11.5% net margin
Low debt · generates free cash flow
Wide moat 73/100

Risks

!Mixed Growth (revenue 5y +11.6 %/yr)
!Trails peers (5/13)
Evidence: High Range $29.66 – $49.44

Fair value as of: Sep 3, 2026

From 4 valuation models · updated yesterday

Share price +16.2% over the past month.

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

What matters now

  • The price sits above even our optimistic bull case ($49.44). The favourable scenario is already priced in.
  • Solid but not exceptional quality (68/100) and above fair value, neither a clear bargain nor a standout compounder.
  • For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.

Price vs Fair Value (5 years)

$128.46 $39.69 Fair Value $39.55 Jun 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 3, 2026.

How to read this chart

60‑month range $39.69 – $128.46 · fair‑value band $29.66 – $49.44 · the $68.68 price screens above the $39.55 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 3, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

CorVel Corp (CRVL) currently trades at $68.68, while our model-based Fair Value estimate is $39.55, implying the stock looks roughly 73.6% overvalued today. The Quality Score stands at 68/100 (solid quality), in the Financial Services sector. Bull case: the Multiples group reads highest at a median of $34.78 per share, and 0 of the 4 models we run sit above the $68.68 price. Bear case: the Asset-Based group reads lowest at $5.18, and 4 of the 4 models stay below the price. Evidence for this calculation is high.

Over the trailing twelve months, CorVel Corp generated revenue of $959M at a net margin of 11.5%. Revenue grew 7.4% year over year. It earns a return on equity of 30.8%. The balance sheet holds a net cash position of $212M. Fundamentals as of Sep 3, 2026

Our scenario range runs from $29.66 (bear case) to $49.44 (bull case); at $68.68, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 38% below its 52-week high and 53% above its 52-week low, currently above its 200-day average. For context, the median of 10 Financial Services peers we cover trades at −42% fair-value upside, at −42%, CRVL screens richer than that median.

Fair Value models

This estimate rests on fiscal year 2026 figures, and about 5 months have passed since. In that time the company retained roughly $0.9264 per share, which is 2.3 % of the fair value. The fair value deliberately does not add this in: the models value reported figures, not a projection.

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Residual Income $13.94 $19.12 $114.64 64
P/E Multiple $35.69 $47.59 $59.49 63
P/B Multiple $26.08 $34.78 $43.47 55
All 4 models by family
Multiples
P/E Multiple $35.69 $47.59 $59.49 63
P/B Multiple $26.08 $34.78 $43.47 55
Asset-Based
NCAV (Graham) $3.86 $5.18 $7.73 54
Economic Profit
Residual Income $13.94 $19.12 $114.64 64

Widest divergence: Multiples ($34.78) versus Asset-Based ($5.18). Highest evidence: Residual Income (64).

Notify me when CRVL reaches fair value

Put CRVL on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Free, no payment details. Unsubscribe anytime in one click.

Key figures & financial health

P/E ratio 32.1
P/S ratio 3.69 P/E × margin
EPS (TTM) $2.14 price ÷ EPS = P/E 32.1
Net margin 11.5% FY2026
Return on equity 30.8% TTM
Return on assets (EBIT) 21.4% avg 5y
More key figures
Profitability
Operating margin 16.0% TTM
Growth
Revenue (TTM) $959M TTM
Revenue growth (YoY) +7.4% 3y avg +10.1%
EPS growth (YoY) +18.9%
Balance sheet & cash flow
Free cash flow $110M FY2026
Net cash $212M FY2026

Figures from reported company fundamentals · as of Sep 3, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 68/100

Of which business quality 68 · Market factors (momentum, volatility) 42

Profitability 82
Margins and returns on capital today
Quality Growth 42
Are margins and returns improving?
Cashflow 59
Earnings quality: real cash, not paper profit
Fin. Strength 83
Balance sheet, leverage, solvency risk
Investment 32
Disciplined investing over empire-building
Low Volatility 49
Calm price path (market factor)
Momentum 46
Price trend over the last 3–12 months (market factor)
52W Momentum 27
Distance to the 52-week high (market factor)
Net Issuance 89
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.

About the company

CorVel Corporation provides workers' compensation, general and auto liability, and hospital bill auditing and payment integrity solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs.

Full company description

CorVel Corporation provides workers' compensation, general and auto liability, and hospital bill auditing and payment integrity solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing; preferred provider management and reimbursement; retrospective utilization, facility claim, and professional review; pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions. In addition, it provides a range of patient management services, such as claims management customers, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, and life care planning, as well as processing of claims for self-insured payors with respect to property and casualty insurance. The company offers solutions to employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. CorVel Corporation was incorporated in 1987 and is based in Fort Worth, Texas.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

CorVel Corp reported revenue of $959M in FY2026 versus $646M in FY2022, a compound +10.4%/yr. Reported net income was $110M in FY2026, compounding +13.5%/yr from FY2022.

Growth Quality 95/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2026)
$959M
Latest YoY
+7.0%
Avg. revenue growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+10.1%
Avg. revenue growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+11.6%
Avg. revenue growth/yr (35Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+10.5%
Value creation/yr (5Y) Earnings growth per share (CAGR 5 years) plus dividend yield: value created per share and year.
−3.1% (−3.1 + 0.0)
Revenue +10.4%/yr
FY22 $646M
FY23 $719M
FY24 $795M
FY25 $896M
FY26 $959M
Net income +13.5%/yr
FY22 $66.4M
FY23 $66.4M
FY24 $76.3M
FY25 $95.2M
FY26 $110M
Character of growth · EPS growth decomposed (2015-2026) +2.6 % p.a.
Revenue per share −4.2 %

of which total revenue +6.4 % · buybacks/dilution −10.0 %

EBIT margin +4.4 %
Tax rate +2.6 %
Residual (interest, one-offs) +0.0 %

Annual growth per factor. These are factors, not summands: multiplied they give the EPS growth rate, added they do not quite. Start and end points are 3-year averages (details on hover).

CRVL screens 74% overvalued. Compare with Marsh & McLennan Companies, Inc →

Share or link this analysis
𝕏 Post WhatsApp LinkedIn Reddit
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "CorVel Corp Fair Value". https://www.fairvalue-calculator.com/stock/CRVL

Earlier news

External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.

Peer Group

Insurance Brokers · 36 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 67 · Above median
Fair Value upside −42% · Below median
Return on equity (TTM) 31% · Top 25%
Return on assets 15% · Top 25%
Net margin (TTM) 12% · Above median
Operating margin (TTM) 16% · Below median
Revenue growth 7% · Below median

Valuation Multiples vs Insurance Brokers median · lower = cheaper

P/E (TTM) 32.1× · Pricier than 75% of peers
P/B 8.06× · Pricier than 75% of peers
P/S (TTM) 3.32× · Pricier than median
P/FCF 28.8× · Pricier than 75% of peers
EV/EBITDA 16.8× · Pricier than 75% of peers

Strength profile in five axes (Snowflake)

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE0 · sector 0
FUTURE37 · sector 66
PAST100 · sector 60
HEALTH100 · sector 88
DIVIDEND0 · sector 80

VALUE 0: the price sits above our fair-value range.

Insider activity: 46/100

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Insurance Brokers stocks, each showing price versus our Fair Value estimate (as of Sep 3, 2026).

Stock Price Fair Value vs Fair Value
Marsh & McLennan Companies, Inc MRSH $193.40 $112.25 −42%
Aon plc AON $352.36 $224.91 −36%
Arthur J. Gallagher & Co AJG $267.56 $75.58 −72%
Willis Towers Watson Public Limited WTW $350.75 $220.92 −37%
Brown & Brown, Inc BRO $71.39 $40.43 −43%
Erie Indemnity Company ERIE $260.40 $113.32 −56%
PB Fintech Limited POLICYBZR ₹1,791 ₹205.02 −89%
Neptune Insurance Holdings NP $32.70 $3.52 −89%
Steadfast Group SDF A$5.27 A$3.92 −26%
Accelerant Holdings ARX $19.67 $30.47 +55%

Compare CorVel Corp with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Financial Services stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screener Filter by region, size and sector Compare tool Two stocks side by side Extrinsic Value Calculator (Options) Splits an option premium into intrinsic and extrinsic (time) value. Peter Lynch Fair Value Formula & Calculator Apply Peter Lynch's fair value formula in seconds: fair P/E ≈ earnings growth (+ dividend) - free, with formula and example.

Frequently asked questions

Is CorVel Corp (CRVL) overvalued or undervalued?
As of Sep 3, 2026, our model estimates a fair value of $39.55 versus a price of $68.68, about −42% upside (overvalued).
What is the fair value of CRVL?
Our model-based fair value for CorVel Corp is $39.55 (as of Sep 3, 2026), built from audited fundamentals. The current price: $68.68.
What is the quality score of CRVL?
CorVel Corp has a Quality Score of 68/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of CorVel Corp (CRVL)?
CorVel Corp reported trailing-twelve-month revenue of about $959M (latest available figure, as of Sep 3, 2026).
What is the net profit margin of CRVL?
The net profit margin of CorVel Corp is about 11.5%, meaning it keeps roughly 11.5% of revenue as net income. Based on the latest reported figures.
Free · no account needed

Watch CorVel Corp in the live analysis

One click puts CorVel Corp on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.